Skip to playerSkip to main content
  • 8 hours ago
Speaking to ETV Bharat, Professor Rawat said in the Phase 2 trial, the drug will be tested for the first time on actual Parkinson's patients.

Category

🗞
News
Transcript
00:08For more information visit www.fema.gov
00:58For more information visit www.fema.gov
01:28For more information visit www.fema.gov
01:58For more information visit www.fema.gov
02:28For more information visit www.fema.gov
02:29For more information visit www.fema.gov
Comments

Recommended